Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Chen, Wei Prof. Dr. (1) Daniel, Peter Prof. Dr. (1) Janz, Martin Dr. (8) Kirchner, Marieluise Dr. (1) Landthaler, Markus Prof. Dr. (1) Rajewsky, Nikolaus Prof. Dr. (1) Wolf, Jana Prof. Dr. (1) Wollert-Wulf, Brigitte (2) (-) Lusatis, Simone (1) (-) Mathas, Stephan Dr. (8) (-) Selbach, Matthias Prof. Dr. (9) (-) Biologie maligner Lymphome (8) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Intrazelluläre Proteolyse (1) Mathematische Modellierung zellulärer Prozesse (1) (-) Proteom Dynamik (9) RNA Biologie und Posttranscriptionale Regulation (1) Systembiologie von Gen-regulatorischen Elementen (1) 1999 (3) 2000 (1) 2001 (4) 2002 (8) 2003 (2) 2004 (4) 2005 (6) (-) 2006 (6) 2007 (4) 2008 (7) 2009 (9) 2010 (6) (-) 2011 (11) 2012 (5) 2013 (5) 2014 (14) 2015 (15) 2016 (10) 2017 (9) 2018 (7) 2019 (6) 2020 (8) 2021 (15) 2022 (14) 2023 (12) 2024 (2) 17 Ergebnisse: Active Filter: Lusatis, SimoneMathas, Stephan Dr.Selbach, Matthias Prof. Dr.Biologie maligner LymphomeProteom Dynamik20062011 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. November 2011 / Biospektrum In vivo-SILAC: Quantitative Analyse der Proteomdynamik [In vivo-SILAC: Quantitative analysis of proteome dynamics] M. Kirchner M. Selbach 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 01. Juli 2006 / Blood Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma J.I. Martin-Subero I. Wlodarska C. Bastard J.M. Picquenot J. Hoeppner M. Giefing W. Klapper R. Siebert S. Mathas S. Joos H. Stein B. Doerken 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 01. November 2011 / Br J Haematol BAY 43-9006/Sorafenib blocks CSF1R activity and induces apoptosis in various classical Hodgkin lymphoma cell lines K. Ullrich K.D. Wurster B. Lamprecht K. Koechert A. Engert B. Doerken M. Janz S. Mathas 01. Januar 2011 / Methods Mol Biol Whole cell proteome regulation by microRNAs captured in a pulsed SILAC mass spectrometry approach O.A. Ebner M. Selbach 19. Mai 2011 / Nature Global quantification of mammalian gene expression control B. Schwanhaeusser D. Busse N. Li G. Dittmar J. Schuchhardt J. Wolf W. Chen M. Selbach 01. August 2011 / Mol Biol Cell Yos9p assists in the degradation of certain non-glycosylated proteins from the endoplasmic reticulum L.A. Jaenicke H. Brendebach M. Selbach C. Hirsch 05. August 2011 / Mol Cell Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR S. Lebedeva M. Jens K. Theil B. Schwanhaeusser M. Selbach M. Landthaler N. Rajewsky Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. November 2011 / Biospektrum In vivo-SILAC: Quantitative Analyse der Proteomdynamik [In vivo-SILAC: Quantitative analysis of proteome dynamics] M. Kirchner M. Selbach
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
01. Juli 2006 / Blood Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma J.I. Martin-Subero I. Wlodarska C. Bastard J.M. Picquenot J. Hoeppner M. Giefing W. Klapper R. Siebert S. Mathas S. Joos H. Stein B. Doerken
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
01. November 2011 / Br J Haematol BAY 43-9006/Sorafenib blocks CSF1R activity and induces apoptosis in various classical Hodgkin lymphoma cell lines K. Ullrich K.D. Wurster B. Lamprecht K. Koechert A. Engert B. Doerken M. Janz S. Mathas
01. Januar 2011 / Methods Mol Biol Whole cell proteome regulation by microRNAs captured in a pulsed SILAC mass spectrometry approach O.A. Ebner M. Selbach
19. Mai 2011 / Nature Global quantification of mammalian gene expression control B. Schwanhaeusser D. Busse N. Li G. Dittmar J. Schuchhardt J. Wolf W. Chen M. Selbach
01. August 2011 / Mol Biol Cell Yos9p assists in the degradation of certain non-glycosylated proteins from the endoplasmic reticulum L.A. Jaenicke H. Brendebach M. Selbach C. Hirsch
05. August 2011 / Mol Cell Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR S. Lebedeva M. Jens K. Theil B. Schwanhaeusser M. Selbach M. Landthaler N. Rajewsky